NextGen Healthcare vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 55)
NextGen Healthcare logo

NextGen Healthcare

ChallengerHealthcare

Practice Management

Ambulatory EHR platform serving 155K providers taken private by Thoma Bravo for $1.8B; behavioral health specialty depth and AI clinical documentation modernization.

AI VisibilityBeta
Overall Score
C55
Category Rank
#169 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
50
Gemini
50

About

NextGen Healthcare is a healthcare information technology company providing electronic health record (EHR), practice management, and healthcare IT solutions primarily to ambulatory healthcare practices — physician offices, specialty clinics, and community health centers. Founded in 1974 (as Quality Systems Inc.) and headquartered in Horsham, Pennsylvania, NextGen Healthcare was taken private by Thoma Bravo in a $1.8 billion acquisition in 2023, joining a private equity firm with significant health IT portfolio investments.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
up
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

55
Overall Score
90
#169
Category Rank
#2
74
AI Consensus
83
stable
Trend
up
52
ChatGPT
92
50
Perplexity
93
50
Gemini
89
50
Claude
96
60
Grok
95

Key Details

Category
Practice Management
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only NextGen Healthcare
Practice Management

Integrations

Only NextGen Healthcare
Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.